Literature DB >> 15236914

The immunostimulating and antimicrobial properties of lithium and antidepressants.

Julian Lieb1.   

Abstract

Eicosanoids are products of arachidonic acid (AA), an essential fatty acid. They include prostaglandins (PGs), prostacyclin (PGI2), thromboxanes (TXs), leukotrienes (LTs) and hydroxy fatty acids. AA is derived enzymatically from membrane phospholipids and to a lesser extent the diet. Eicosanoids self-regulate every cell, including those synthesizing serotonin, norepinephrine and dopamine and those subserving immune function, such as T-cells, B-cells, natural killer cells, macrophages, monocytes and dendritic cells. There is objective evidence that prostaglandins regulate the physiology of the hypothalamic-pituitary-adrenal axis (HPA). Elucidation of the structure and metabolic pathways of eicosanoids galvanized researchers into illuminating their role in physiology, pathology and pharmacology. Striking contradictions arose: eicosanoids were shown to activate and suppress microorganisms, potentiate and suppress immunity and possess pro- and anticancer properties. As prostaglandins are the most heavily studied eicosanoids in the context of mood and immunity I will focus on them in this article. I will present evidence of the immunostimulating and antimicrobial properties of lithium and antidepressants and propose that these properties are linked to the antiprostaglandin actions of these compounds.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15236914     DOI: 10.1016/j.jinf.2004.03.006

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  11 in total

Review 1.  Anxiety, Depression, and the Microbiome: A Role for Gut Peptides.

Authors:  Gilliard Lach; Harriet Schellekens; Timothy G Dinan; John F Cryan
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

2.  Mood stabilizing drugs regulate transcription of immune, neuronal and metabolic pathway genes in Drosophila.

Authors:  L Herteleer; L Zwarts; K Hens; D Forero; J Del-Favero; P Callaerts
Journal:  Psychopharmacology (Berl)       Date:  2016-02-06       Impact factor: 4.530

3.  Lithium inhibits growth of intracellular Mycobacterium kansasii through enhancement of macrophage apoptosis.

Authors:  Hosung Sohn; Kwangwook Kim; Kil-Soo Lee; Han-Gyu Choi; Kang-In Lee; A-Rum Shin; Jong-Seok Kim; Sung Jae Shin; Chang-Hwa Song; Jeong-Kyu Park; Hwa-Jung Kim
Journal:  J Microbiol       Date:  2014-02-17       Impact factor: 3.422

4.  Gut microbes in neurocognitive and mental health disorders.

Authors:  Tyler Halverson; Kannayiram Alagiakrishnan
Journal:  Ann Med       Date:  2020-08-31       Impact factor: 4.709

5.  Defeating cancer with antidepressants.

Authors:  J Lieb
Journal:  Ecancermedicalscience       Date:  2008-08-21

6.  Microbial challenge test of a novel epoprostenol sodium formulation.

Authors:  Dirk Bandilla; Marcel Goverde; Paolo Giudici; Olivier Lambert
Journal:  Drug Des Devel Ther       Date:  2017-08-10       Impact factor: 4.162

7.  Fecal Microbiota Analysis in Patients Going through a Depressive Episode during Treatment in a Psychiatric Hospital Setting.

Authors:  Paweł Liśkiewicz; Justyna Pełka-Wysiecka; Mariusz Kaczmarczyk; Igor Łoniewski; Michał Wroński; Agata Bąba-Kubiś; Karolina Skonieczna-Żydecka; Wojciech Marlicz; Błażej Misiak; Jerzy Samochowiec
Journal:  J Clin Med       Date:  2019-02-01       Impact factor: 4.241

8.  A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode.

Authors:  Annamaria Painold; Sabrina Mörkl; Karl Kashofer; Bettina Halwachs; Nina Dalkner; Susanne Bengesser; Armin Birner; Frederike Fellendorf; Martina Platzer; Robert Queissner; Gregor Schütze; Markus J Schwarz; Natalie Moll; Peter Holzer; Anna K Holl; Hans-Peter Kapfhammer; Gregor Gorkiewicz; Eva Z Reininghaus
Journal:  Bipolar Disord       Date:  2018-07-26       Impact factor: 6.744

9.  Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties.

Authors:  Bruk Getachew; Joseph I Aubee; Richard S Schottenfeld; Antonei B Csoka; Karl M Thompson; Yousef Tizabi
Journal:  BMC Microbiol       Date:  2018-12-22       Impact factor: 3.605

10.  The change of gut microbiota in MDD patients under SSRIs treatment.

Authors:  Yang Shen; Xiao Yang; Gaofei Li; Jiayu Gao; Ying Liang
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.